[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609586":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":36,"responsibleParty":53,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":72,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants post liver transplant",null,"Participants who are discharged from after liver transplant.",[13],"Device: Libre 3+",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Libre 3+","Blinded CGM will be worn by all participants",[9],[21],"blinded CGM",[23],{"name":24,"affiliation":5,"role":25},"Grenye O'Malley, MD","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Grenye O'Malley","CONTACT","212-241-7173","grenye.o'malley@mssm.edu",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Alexa Brett","212-241-7586","alexa.brett@mssm.edu",[37],{"facility":38,"status":39,"city":40,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Mount Sinai Hospital","RECRUITING","New York","10029","United States",{"type":44,"coordinates":45},"Point",[46,47],-74.00597,40.71427,{"lat":47,"lon":46},[50,51,52],{"name":24,"role":29,"phone":30,"phoneExt":10,"email":31},{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},{"name":28,"role":25,"phone":10,"phoneExt":10,"email":10},{"type":25,"investigatorFullName":28,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Associate Professor","100609586",false,"NCT07216508","Liver Transplant CGM","Post-discharge Glycemic Control After Liver Transplant and Impact on Transplant Outcomes","Inclusion Criteria:\n\n• inpatient liver transplant participants who have had an inpatient glucose greater than 180mg\u002FdL\n\nExclusion Criteria:\n\n* having a planned discharge to a rehabilitation or nursing facility,\n* a contraindication to sensor placement,\n* if discharge is anticipated to be \\>30 days post-transplant, or\n* if recent transplant also included a kidney or pancreas transplant","ALL","18 Years",{"count":64,"type":65},40,"ESTIMATED","OBSERVATIONAL","This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.",[69,70,71],"Liver Transplant","Post Transplant Diabetes","Type 2 Diabetes",[73,74,75,76,77],"liver transplant","hyperglycemia","diabetes","continuous glucose monitoring","glucose sensor","2025-11-10",{"date":80,"type":81},"2025-11-12","ACTUAL",{"date":83,"type":81},"2025-10-13",{"date":85,"type":65},"2027-10-05",{"name":5,"class":6},1]